Healthcare Use Case

AI Governance for Payer-Provider Data Exchange and Risk Adjustment

AI agents automating FHIR-based data exchange, prior authorization, and HCC risk adjustment coding require governance that existing frameworks do not natively provide: a distinct non-human identity for cross-organizational API calls, least-privilege scoping enforced at the tool-call level, and audit trails that link every AI-suggested code to source documentation for RADV defensibility.

Request a Demo Talk to an Expert

AI Agents Now Sit Inside Regulated Data Exchange Pathways

Payers and providers are increasingly using AI agents to automate FHIR-based data exchange, prior authorization workflows, and risk adjustment coding support. These agents call payer and provider APIs governed by CMS-0057-F, the ONC Cures Act Final Rule, and TEFCA, and in many workflows they chain multiple calls in sequence: an eligibility check, a clinical record retrieval, a coding suggestion, and a submission, each carrying a different scope of PHI access.

The interoperability standards behind these calls, including HL7 FHIR and SMART on FHIR's OAuth 2.0 authorization flows, were designed around human-authorized sessions. They do not define a distinct identity class for an agent acting without direct human initiation at the moment of the call. That gap is the starting point for governance risk in payer-provider AI deployments. It is an architectural mismatch between how exchange standards were built and how agents actually operate, not a general AI safety concern.

Existing Obligations Apply, But Guidance Has Not Caught Up

The HIPAA Security Rule (45 CFR 164.312) requires access control, audit control, and unique user identification for any system that creates, receives, maintains, or transmits ePHI. These requirements apply to AI agent components processing PHI in the same way they apply to any other system function, meaning agent accounts require documented, minimum-necessary access justification. HIPAA Business Associate Agreement obligations also extend to any vendor or subcontractor performing that function on a covered entity's behalf, including AI vendors, and those agreements should explicitly address agent-specific data handling, logging, and audit obligations.

NIST's AI Risk Management Framework offers voluntary lifecycle guidance covering third-party and autonomous system risk, but it is not a compliance standard. No CMS or HHS guidance identified to date directly addresses autonomous AI agents operating within FHIR-based payer-provider exchange. Deploying organizations are responsible for mapping existing HIPAA and CMS obligations onto agentic architectures themselves, and increased CMS scrutiny of Medicare Advantage risk adjustment payments raises the stakes for documenting how AI-suggested codes were generated and validated.

Where Governance Gaps Concentrate

Three architectural points (plus human review) determine whether an AI agent operating across payer-provider boundaries can be governed and audited defensibly.

Agent Identity

Distinct, non-human credentials for cross-organizational FHIR and claims API calls.

Least-Privilege Scoping

Tool-call-level access limits across eligibility, coding, and submission steps.

Audit Trail Provenance

Logs that capture model, source documents, and confidence, not just access events.

Human Review Checkpoints

Mandatory sign-off before AI-influenced codes or PHI transmissions finalize.

Where Runtime Governance Fits

The gaps described above are structural: identity, permissioning, and audit logging for AI agents are not addressed by SMART on FHIR authorization flows, TEFCA's participant accountability model, or general HIPAA guidance written before agentic systems existed. Runtime governance is the layer that sits between the agent and the payer or provider systems it calls, enforcing identity issuance, least-privilege tool-call policy, and audit logging that captures decision provenance rather than only data access events.

Trussed AI provides runtime governance and security for enterprise AI agents, including agent identity, least-privilege permissioning, tool approval workflows, and audit logging. For AI governance leaders evaluating agents in payer-provider and risk adjustment workflows, these are the specific controls to confirm are present, independent of which platform provides them.

  1. Issue agent identity

    Provide scoped, non-human credentials for cross-organizational API access, separate from human user accounts.

  2. Enforce tool-call policy

    Limit PHI scope and duration per task (eligibility, coding, prior authorization) at the individual tool call.

  3. Capture decision provenance

    Record model version, source documents, and confidence alongside each AI-suggested code or transmission.

  4. Require human checkpoints

    Block finalization of risk-adjustment codes or PHI submissions until required review is complete.

Implementation Considerations

  • Map every AI agent tool or API call to a specific HIPAA-covered function and confirm Business Associate Agreement coverage before production deployment.
  • Issue agent-specific, scoped, time-limited credentials distinct from human user accounts for all cross-organizational data calls.
  • Build immutable, queryable audit trails linking AI-suggested HCC codes to source clinical documentation.
  • Define mandatory human-in-the-loop checkpoints for AI-suggested diagnosis codes or PHI transmissions that affect risk scores or claims submission.
  • Test agent behavior against CMS-0057-F-required FHIR endpoints under realistic payer and provider API constraints before go-live.

Evaluation Criteria Before Production Deployment

Use these questions to assess whether identity, permissioning, audit, and contractual controls are ready before agents touch PHI in production.

  • How does the agent authenticate to external EHR, claims, and FHIR APIs, and is that identity distinct from human user credentials?
  • What is the scope and duration of PHI access granted per task, such as eligibility check, coding suggestion, or prior authorization submission?
  • Can the platform produce an audit trail linking each AI-suggested HCC code to its source documentation and model version?
  • What human review checkpoints exist before AI-influenced risk-adjustment codes or PHI transmissions are finalized?
  • How are Business Associate Agreement obligations extended to the AI agent vendor and any subcontracted model or infrastructure providers?
  • Has agent behavior been tested against CMS-0057-F-required FHIR endpoints under realistic payer and provider API constraints prior to go-live?

Frequently Asked Questions

Does HIPAA specifically regulate AI agents?

HIPAA does not name AI agents directly, but the Security Rule's access control, audit control, and unique user identification requirements apply to any system function that creates, receives, maintains, or transmits ePHI, which includes agent components performing that function.

Is there CMS guidance for autonomous agents in prior authorization workflows?

No CMS or HHS guidance identified addresses autonomous agents in FHIR-based exchange directly. CMS-0057-F API requirements and HIPAA obligations apply by extension, and organizations must map them onto agent architecture themselves.

What makes an audit trail sufficient for RADV defense?

Traceability linking each submitted HCC code to source clinical documentation, plus provenance for AI-suggested codes, including model or version, source documents referenced, and confidence indicators, not just system access logs.

Does TEFCA participation cover AI agent activity?

TEFCA assigns accountability to participants and subparticipants for downstream data use but does not specify controls for AI agents consuming or acting on exchanged data. Organizations remain accountable for mapping agent actions to a responsible participant.

Evaluate Runtime Governance Before Agents Touch PHI

Confirm agent identity, least-privilege access, and audit logging are in place before deploying AI agents in payer-provider data exchange or risk adjustment workflows.

Request a Demo